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Chemicals capable of producing structural and chemical changes on cells are used to treat 
diseases (e.g. cancer). Further development and optimization of chemotherapies require 
thorough knowledge of the effect of the chemical on the cellular structure and dynamics. This 
involves studying, in a non-invasive way, the properties of individual cells after drug 
administration. Intracellular viscosity is affected by chemical treatments and it can be reliably 
used to monitor chemotherapies at the cellular level. Here, cancer cell monitoring during 
chemotherapeutic treatments is demonstrated using intracellular allocated upconverting 
nanorockers. A simple analysis of the polarized visible emission of a single particle provides 
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a real-time readout of its rocking dynamics that are directly correlated to the cytoplasmic 
viscosity. Numerical simulations and immunodetection are used to correlate the measured 
intracellular viscosity alterations to the changes produced in the cytoskeleton of cancer cells 
by anticancer drugs (colchicine and Taxol). This study evidences the possibility of 
monitoring cellular properties under an external chemical stimulus for the study and 
development of new treatments. Moreover, it provides the biomedical community with new 
tools to study intracellular dynamics and cell functioning. 
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1. Introduction 
Rheological parameters, such as creep compliance, viscosity or elasticity, are of great 
importance at the cellular level. Cytoplasmic viscosity controls the diffusion and transport of 
molecules and organelles inside the cell. It is also a reliable indicator of the cellular state, 
which can be used to detect the appearance and onset of different diseases, including 
cancer.[1] The precise knowledge of the intracellular viscosity can be used to evaluate the 
effects caused by different treatments at the single-cell level. Indeed, cytoplasmic viscosity is 
modified when cancer cells are subjected to a chemotherapy process, so that variations in the 
intracellular viscosity can be used to assess the evolution of the treatment.[2] The intracellular 
environment is a composite of water and a variety of proteins and organelles. One of the main 
protein components of the cytoplasm is the cytoskeleton. This three-dimensional network 
composed of filamentous proteins is a highly mobile, viscoelastic and flexible entity that 
controls the cellular mechanics.[3] Particularly, alterations produced in the intracellular 
viscosity due to drug administration are governed by the effect of the chemical on the 
cytoskeleton of the cell. There are three major types of cytoskeletal filaments: microtubules, 
actin filaments, and intermediate filaments. They differ from each other in their molecular 
structure, function and mechanical properties. These filamentous proteins, and other 
associated proteins, have very different dynamics and changes in their local concentration 
affect the viscosity of the cytoplasm. 
After many years of research, various natural, semi-synthetic and synthetic compounds have 
been developed to control the growth of cancer cells or tissue. These anticancer agents are 
broadly classified as alkylating agents, antimetabolites, antibiotics, natural products (e.g. 
colchicine and Taxol), and hormones.[4] Anticancer drugs mainly prevent cell division by 
blocking sites of action and inhibiting enzyme release. Based on their targets, anti-cancer 
agents are classified into tubulin and non-tubulin interactors. Tubulin is a heterodimer formed 
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by two globular protein subunits, α- and β-tubulin.[5] They polymerize to form the 
microtubules, which are in a continuous dynamic cycle of polymerization and 
depolymerization. Through these dynamic mechanisms, microtubules are one of the 
important components of cell division: they produce the mitotic spindle at anaphase to form 
new daughter cells.[6] Drugs that interfere with the polymerization and depolymerization of 
microtubules are called tubulin interactors.[7] Depending on their interference action, they are 
classified into two categories.[8] Tubulin destabilizing agents, such as colchicine, inhibit 
tubulin polymerization, causing the shortening of the microtubules and a net decrease in its 
number.[9] On the other hand, tubulin stabilizing agents, such as Taxol, stabilize 
microtubules, enhance tubulin polymerization, and reduce tubulin heterodimers concentration 
in the cytoplasm.[5a] In either case the microtubule dynamics are disrupted and the mitotic 
spindle cannot be formed.[10] 
Unfortunately, these drugs are associated with severe side effects in somatic cells and tissues 
due to the non-selectivity of the anti-cancer agents toward the cancer cells. Specificity in the 
treatment is an important aspect in order to reduce the toxicity, whereas it is difficult to 
obtain because cancer cells are similar to normal cells.[11] However, the treatment will affect 
differently each type of cell due to their different division rate. Most somatic cells in the body 
are not dividing, so drugs actin on microtubule dynamics have little effect on their cell 
division. On the other hand, tumor cells have a high rate of proliferation which makes them 
more likely to be affected by the treatment, favoring the inhibition of tumor growth. 
Each type of tubulin interactor has a different impact on the intracellular viscosity so that the 
monitoring of the viscosity changes can be used to control the efficacy of the treatment at the 
single-cell level. Such monitoring must be done in a non-invasive (contactless) way so that 
the measured changes could be only attributed to the effect of the administrated drug. 
Measuring cytoplasm properties in such an invasive way is a challenging endeavor. Through 
  
5 
 
decades, different rheometric techniques have been developed for single-cell studies.[1a, 12] 
They can be divided into passive and active methods. Active techniques impose an external 
force in order to produce a controlled deformation of the cell to measure its reaction to the 
applied stimulus.[13] On the other hand, passive techniques are based on the analysis of the 
thermal fluctuations of endogenous (intracellular material) and exogenous (particles) entities 
inside the cell.[1a, 2c, 14] These technics are less invasive than active methods and can be 
combined with luminescent nanoparticles or molecules to improve spatial resolution.[15] 
Single-particle spectroscopy has served to reduce the number of agents (ideally just one) 
required for imaging or sensing. This technique can be combined with passive rheometric 
techniques for viscosity measurements. For this purpose, upconverting particles (UCPs) are 
the perfect candidate ought to their outstanding luminescent properties and biocompatibility. 
This kind of luminescent particles can produce visible emission under infrared excitation via 
a multiphoton excitation process.[16] Moreover, stable and non-blinking emission enables 
prolonged measurements of the luminescence of a single UCP, required for specific studies. 
In addition, the shape and size of UCPs can be tailor-made for the phenomenon to be studied. 
As an example, the polarized emission of non-spherical UCPs gives additional information 
on the dynamics of the particle (i.e. not only location and translation, but also rotation) inside 
a liquid and it can serve to extract information of the viscosity of the surrounding medium.[17] 
Moreover, UCPs of sizes ranging from few nanometers to tens of micros can be used to 
explore viscosity in a wide range of scales. As it will be explained later, the measured value 
of the intracellular viscosity strongly depends on the size of the agent used to measure it.[18] 
A non-spherical particle (i.e. disk) inside a fluid, in addition to diffuse, “rocks” due to the 
collision of the molecules of the fluid with the particle. The magnitude of this angular 
vibration depends not only on temperature, but also on the viscosity of the fluid. This 
vibrational movement can be characterized by the mean square angular displacement 
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(MSAD), whose evolution with time (t), in the particular case of a disk-shaped particle, is 
given by 
𝑀𝑆𝐴𝐷(𝑡) =
𝑘𝐵𝑇
3𝜂𝑉𝑓 𝑓0⁄
𝑡.        (1) 
This equation takes into account the intracellular viscosity (η), the thermal energy (kBT, 
where kB is the Boltzmann constant, and T the temperature) and the characteristics of the 
particle (volume, V, and Perrin’s friction coefficient, f / f0, a parameter that relates the friction 
of the non-spherical object with that of a sphere of equivalent volume).[19] Thus, the time 
evolution of the MSAD of a non-spherical particle inside a cell provides a direct 
measurement of the cytoplasmic viscosity. 
Determining the time evolution of the MSAD of a nanoparticle inside a living cell is 
challenging. Conventional approaches, such as video-based techniques cannot be applied due 
to the small dimensions of the particle.[14d, 20] In this work, we face this problem by using 
non-spherical upconversting nanoparticles (UCNPs). Our nanorockers are disk-shaped β-
NaYF4 nanoparticles with a mean radius and thickness of 400 nm, as shown in the SEM 
image of Figure 1a. This particle´s size allows us to measure changes in the mesoscopic 
viscosity of the cell. As mentioned above and will be discussed later, the viscosity that affects 
the movement of the particle depends on its relative size to that of the intracellular 
components. Very small particles are only able to measure the cytosolic viscosity, whose 
value is of the order of that of water. External agents (i.e. drugs) do not affect the cytosolic 
but the mesoscopic viscosity. For this reason, we select this particle size. The nanoparticles 
are doped with Er3+ and Yb3+ ions. This combination of dopants and host material ensured an 
intense visible emission (500-700 nm) under 980 nm excitation. Due to the particular crystal 
structure of β-NaYF4, our disk-shaped nanorockers showed a red emission band that is highly 
polarized. Therefore, for a fixed detection geometry, the spectral shape of the emission 
depends on the angular position of the nanorocker. This makes possible a straightforward 
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measurement of the time evolution of the MSAD. This, in turn, allows us to determine the 
evolution of intracellular viscosity during cancer cell treatment by a simple analysis of the 
fluctuations in the luminescence of the disk-shaped UCNP produced by its vibration. 
In the present study, we have used upconverting nanorockers to monitor single-cell 
chemotherapeutic processes based on two different anticancer drugs, colchicine and Taxol, 
using the intracellular viscosity as a diagnostic parameter. We correlated the effect of these 
chemicals in the intracellular viscosity to the structural changes of the treated cells. We also 
developed a theoretical model to understand the role played by the cytoskeleton of the cell in 
the viscosity changes. 
2. Experimental design 
Our experimental setup is depicted in Figure 1a and described in the experimental section. 
Briefly, a 980 nm laser beam is focused using a microscope objective to excite the 
luminescence of the target UCNP. We use the same objective to collect the luminescence and 
to image the sample plane using a CMOS camera. The luminescence spectra are analyzed by 
using a CCD camera coupled to a monochromator. 
We used HeLa cancer cells (ATCC) to test the performance of the chemotherapeutic 
treatments (see the experimental section for details). The UCNPs are incorporated by the cells 
prior to the chemical treatment. Once inside the cell, the rocking dynamics of the UCNP are 
influenced by its interaction with the intracellular components, such as microtubules 
(schematically represented in Figure 1b, c and d) and the local density of tubulin 
heterodimers (Figure 1d). 
The rheometric technique we used encompasses four main steps: (i) measurement of the 
polarized luminescence emission of the internalized UCNP, (ii) analysis of these spectra to 
obtain the angular displacement of the particle with time, (iii) determination of the MSAD 
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from the angular displacement, and (iv) fitting of the MSAD to Equation 1 to obtain a value 
of the intracellular viscosity (see the experimental section for more details). 
We determined the temporal evolution of the MSAD of the upconverting nanorockers by 
analyzing the spectral fluctuations of their polarized visible emission.[21] The intensity ratio 
(𝑅 = 𝐼654 𝐼661⁄ ) of the peaks centred at 654 nm and 661 nm (highlighted in Figure 2a) 
strongly depends on the orientation of the particle. Thus, the angular position (𝜃) can be 
elucidated from the relative emission at 654 and 661 nm using 
𝜃(𝑅) = 𝑎𝑐𝑜𝑠⁡ (√
𝑅𝑚𝑎𝑥−𝑅
𝑅𝑚𝑎𝑥−𝑅𝑚𝑖𝑛
),        (2) 
where 𝑅𝑚𝑖𝑛 = 𝑅(𝜃 = 0) is the minimum value of the intensity ratio reached when the 
particle is horizontally orientated (i.e. with the largest facet perpendicular to the beam 
propagation direction). Similarly, 𝑅𝑚𝑎𝑥 = 𝑅(𝜃 = 𝜋 2⁄ ) is the maximum value when the 
particle is vertically orientated (i.e. its largest facet parallel to the beam propagation 
direction). To determine the angular thermal fluctuations of the internalized nanorocket (i.e. 
the 𝜃 vs t curve), we recorded consecutive luminescent spectra for a total measurement time 
of approximately 4 minutes (set of gray spectra in Figure 2a). The used laser intensity was 
approximately 106 W/cm2, which ensures a good signal-to-noise ratio without producing cell 
damage. The UCNP must be in the vertical orientation to reduce the action of optical torques 
that can interfere in the Brownian dynamics of the particle (see supporting information).[17] 
Then, we used the measured luminescent spectra to compute the intensity ratio R (see Figure 
2b), which was utilized to obtain a value of the angular displacement of the particle using 
Equation 2. It is worth noting that the determination of the orientation of the particle is made 
by a ratiometric technique. This ensures that, as long as the signal-to-noise ratio is high 
enough to give a resolved spectrum, the value of the intensity ratio does not depend on the 
total emission intensity. Finally, we calculated the MSAD. Figure 2c shows, as an illustrative 
example, the averaged MSAD measured as a function of time for cells incubated for 0.5 
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(black) and 5 (blue) hours with Taxol at 0.2 µM concentration. The linear fit of these curves 
to Equation 1 gives the mean value of the intracellular viscosity of the cells subjected to the 
drug treatment. Note the change in the slope of the MSAD vs time curves that evidences a 
change in the intracellular viscosity as a consequence of Taxol administration, as it will be 
discussed in detail later. 
3. Results and discussion 
3.1. Intracellular viscosity changes 
We used the above-described rheometric technique to quantify the intracellular viscosity of 
HeLa cells when subjected to different chemotherapeutic treatments (see experimental 
section for details). We treated the cells for different periods of time with 0.2 µM of Taxol, 
and with 0.1, and 1 µM colchicine during 2 h. We selected these drug concentrations and 
treatment times because previous studies had shown that they are non-toxic to cells while 
able to produce changes in the intracellular viscosity. Hence, we expected to see similar 
effects on HeLa cells. Results are shown in Figure 3. Data correspond to the mean value of 
all measurements for the given treatment conditions and error bars represent the standard 
deviation. The main source of uncertainty in our measurements is the variability in the cell 
population. For that reason, we chose this parameter as our experimental error. Error 
propagation in Equations 1 and 2 give a smaller uncertainty in the viscosity measurement (~2 
%). 
In the case of Taxol (Figure 3a), the intracellular viscosity decreases with the duration of the 
treatment. An exponentially decreasing function was fitted to the experimental data, which 
gave a decay ratio of 0.8 hours, similar to that published for macrophages (1.16 h) for a drug 
concentration of 0.2 µM.[2c] In addition, results obtained on Taxol-treated neutrophils reveal a 
negligible change in the intracellular viscosity for an incubation time of around 20 min at a 
concentration five times larger than the used in this work.[2b] Even though the effect of the 
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drugs is not expected to be the same on different cell types due to their structural and 
functional dissimilarities, our results and those published in the literature suggest that the 
action of Taxol on the intracellular viscosity, at a particular concentration, is time-dependent. 
On the other hand, the treatment with colchicine produces the reverse effect: as the 
concentration of the drug increases, the viscosity also does (Figure 3b). These results 
additionally suggest that there is a threshold (in our case larger than 0.1 µM) above which the 
viscosity is affected by the drug. Our results show that 0.1 µM of colchicine has a negligible 
effect on cell viscosity since the measured viscosity is, within the experimental error, the 
same as that obtained for the untreated cells. This concentration-dependent effect and 
threshold were also observed for colchicine-treated neutrophils.[2b] In this published work, 
colchicine concentration had to be increased up to 10 µM in order to see a clear increase in 
the intracellular viscosity. Moreover, the two-fold increase in the viscosity showed in Figure 
3b was achieved for that type of cells at a concentration as high as 100 µM. 
It is worth noting that due to their size, the used UCNPs are internalized via endocytosis. This 
could lead to the formation of a membrane between the particle and the cytoplasm. In that 
case, one would expect that the presence of the membrane would affect the measurement 
regardless of the treatment, thus giving the same viscosity value irrespectively of the cell 
state. However, our results show that there is a change in the intracellular viscosity after drug 
administration that affects the particle’s movement. We conclude that this membrane, if 
present, does not prevent the measurement of the viscosity changes, but it may affect the 
absolute value of the measured viscosity. 
3.2. Structural changes 
Once the effect of Taxol and colchicine on the intracellular viscosity was determined, we 
assessed the structural changes induced on the cytoskeleton of HeLa cells by these drugs 
through immunodetection (see the experimental section for details). We show the distinct 
  
11 
 
action of Taxol and colchicine on microtubule structure in the upper panels of Figure 4 and 
Figure S2 of the supporting information. We show the expected microtubule stabilization 
produced by Taxol in the second and third upper panels of Figure 4. The main difference 
between control interphase HeLa cells (first upper panel) and Taxol-treated cells is the 
formation of microtubule bundles. Control cells present an irregular structure of 
microtubules, while in Taxol-treated cells the density of microtubules increases and they 
orient parallelly forming bundles. This is in good agreement with results obtained in HeLa 
cells treated with a micromolar concentration of Taxol.[22] We cannot distinguish any mayor 
difference between the tubulin network of cells incubated for 2 and 5 h. This is in good 
agreement with the similarity in the viscosity values measured for those treatment times (see 
Figure 3a). However, we found differences between control and 5 h incubation time (see 
large field image in Figure S2) in the morphology of Hela cells. As incubation time increases, 
treated cells tend to present a more rounded shape than control cells. In addition, we observed 
that the number of cells in a state between metaphase and anaphase in the cycle of cell 
division (mitosis) increases. This indicates that cells affected by Taxol during mitosis cannot 
longer complete the process since microtubules have lost their dynamic behavior.[22] 
On the other hand, we observed that colchicine presents the opposite effect on microtubules 
to Taxol, as shown by previous studies.[23] In this case, microtubules cannot longer be formed 
thus they remain in the cytoplasm as dimers, as we show in the fifth upper panel of Figure 4. 
When HeLa cells were incubated with 1 µM of Colchicine, microtubules lost their structure 
in the form of filaments and consequently the microtubule network was disrupted. We did not 
see this effect in the cells treated with 0.1 µM of colchicine (fourth upper panel) which is in 
good agreement with the viscosity measurements shown in Figure 3b. 
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In the case of the actin cytoskeleton, we did not observe changes in the distribution of F-actin 
in the cell cytoplasm for any of the treatments, as shown in the bottom panels of Figure 4. 
Actin filaments remained distributed in the form of stress fibers and cortical fibers, as in the 
case of control cells.[24] These results suggest that the viscosity changes we have measured 
are primarily due to alterations in the microtubule cytoskeleton. This is in good agreement 
with previous studies on the HeLa cells treated with Taxol and colchicine.[23] 
3.3. Simulations 
Once structural changes in the treated cells have been discussed, these need to be related to 
the changes in the intracellular viscosity. The immunodetection assay suggests that 
modifications in the microtubule structures are the origin of the viscosity changes. Before 
drug administration, the cytoplasm activity includes the interaction of tubulin dimers with 
different types of microtubule-associated proteins, which form aggregates.[25] It is the 
interaction of these dynamic aggregates, rather than a lateral assembly of individual dimers, 
which produces the formation of protofilaments and short microtubule strands. In this 
scenario, the cytoplasm behaves as a transient gel with aggregated structures. Notably, the 
resulting mesoscopic structures have an average size similar to that of the used nanorokers 
(400 nm). This fact is important because the viscosity of complex fluids, such as the 
cytoplasm, depends on the length-scale of the sample since the Brownian motion of a particle 
in a disordered media samples the local viscosity of length-scales comparable to its size.[18] 
Therefore, the particle will be affected by an effective viscosity which value depends on its 
size in respect to the characteristic size of the fluid components. If the particle is smaller than 
the typical size of the aggregates (Rp << Ra, being Rp and Ra the particle and aggregate 
effective radius, respectively), it samples the viscosity of the solvent where the aggregates are 
dispersed (i.e. cytosolic viscosity). In the mesoscopic regime, when the particle is comparable 
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to the aggregates, the effective viscosity increases exponentially with Rp/Ra until it saturates 
to a macroscopic value for Rp >> Ra.
[18] 
For a typical concentration of tubulin (25-100 µM) in the cytoplasm, the average volume 
fraction of microtubules is between 5 ×10-3 and 10-2. At these concentrations, a polydisperse 
ensemble of rods (i.e. microtubules) with attractive interactions form a fractal gel whose 
pores are typically smaller than the average length of the rods.[26] Accurate simulations of the 
diffusion of the nanorocker in such transient network of short filaments go beyond the present 
contribution as one would require knowledge of, among other factors, the polydispersity of 
the filaments and the interaction potentials. Nevertheless, the diffusion of tracer particles in 
gels present a generic behavior and, in particular, owing to the steric hindrance of the gel 
obstacles, both translational and rotational diffusions are severely reduced typically by one 
order of magnitude and often leading to anomalous diffusion.[26-27] 
Such scenario gradually changes upon administration of Taxol. This drug induces an 
irreversible polymerization of microtubules over time, leading to an increase of the average 
size of the gel pores which favors the rotational diffusion of the nanorocker. The 10-fold 
viscosity decrease observed in Figure 3a indicates that, 5 h after the administration of Taxol, 
the particle is moving around significantly larger structures, i.e. microtubules. Therefore, it is 
sampling scales much shorter than the microtubules and consequently detects a smaller 
effective viscosity. On the other hand, colchicine prevents the formation of filaments and 
aggregates, reducing the average length of the cytoplasm components that drag the particle. 
In this situation, the particle is affected by a larger effective viscosity. 
In addition, in a suspension of rods with a volume fraction of ~ 0.01, a transition from 
disordered to ordered phase takes place once the rods become larger than about 2 µm.[26] This 
length scale is not far from the nanoroker diameter used here (i.e. 800 nm). In the ordered 
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phase, the typical distance between microtubules becomes larger than the nanoroker size and 
the steric hindrance of the microtubules is significantly reduced. Figure 3a indicates that the 
transition to the ordered phase could take place after 2h of Taxol administration. 
To validate this hypothesis, we studied whether or not the mobility of the particle is 
significantly altered by the presence of long microtubules resulting from a prolonged (5 h) 
incubation with Taxol. We performed numerical simulations based on the immersed 
boundary method for Brownian hydrodynamics, which reproduce the particle environment 
after the administration of Taxol.[28] Simulations were carried out in periodic boxes of side L 
= 64 × h, where h is the unit-mesh size, whose value was chosen based on the particle size. 
As shown in Figure 5a, the particle is built up by using a number of spherical beads (of 
radius Rh ≈ h) connected by a network of hard springs to ensure a negligible deformation. 
The width of the particle (400 nm) was set to 8 beads, which approximately corresponded to 
a particle’s hydrodynamic radius of 14 × h, so that h ≈ 28.6 nm and L ≈ 1.83 µm. 
Microtubules were similarly constructed using 3 strands of beads connected with three-body 
potentials, providing a large bending rigidity (see Figure 5a). 
Using a reference concentration of tubulin of 25 µM and a microtubule diameter of 
approximately 50 nm,[25] we estimate that the average number of microtubules crossing a 
surface of one micron square is about 2, although this number varies over the cell. We 
performed simulations with an increasing number of microtubules, with a maximum value of 
20, which corresponds to 6 microtubules per micron square. Two different scenarios were 
considered taking into account the presence or not of the excitation beam. In the “free” case, 
the particle is free to translate and collide with the microtubules. In the “confined” case, the 
particle feels an external potential which confines its translation (but not its rotation) to a 
domain which is about 10 % larger than its volume. In this confined case, any modification of 
the particle rotation is only due to effects of the microtubules on the hydrodynamic mobility 
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of the particle. We note that, in the experiments, the particle might be softly confined due to 
the optical forces. Therefore, a comparison between both scenarios enables a cross-check of 
the significance of the viscosity measurement. We calculated the MSAD for both scenarios 
and, additionally, the translational diffusion (i.e. mean square displacement, MSD) for the 
“free” case. The theoretical MSAD of a perfect disk with the same aspect ratio as our 
nanorokers, given by Equation 1, is plotted in Figure 5b (orange line). This curve matches, 
within statistical uncertainty, to the MSAD obtained with simulations in the absence of 
microtubules, validating the approximation of the UCNP to a disk. We then added 
microtubules to simulate the modification of the viscosity in the “confined” case. Figure 5b 
shows that, up to the concentrations considered, the viscosity sensed by the particle is 
practically not modified by the presence of microtubules. We can conclude from this that, 
once all the microtubules are formed, there is a less amount of intracellular material of 
comparable size to the nanorocker, therefore the Brownian motion of the particle is affected 
by a reduced viscosity. Finally, the simulated MSAD for the free and confined cases are 
similar, showing that the translational confinement of the particle by the excitation beam does 
not restrict or affect its rocking motion. 
4. Conclusion 
In summary, we use the intracellular rocking dynamics of disk-shaped upconverting 
nanoparticles for the determination of the intracellular viscosity of HeLa cancer cells 
subjected to anticancer drugs (i.e. Taxol and colchicine). A simple analysis of the time 
evolution of the visible emission generated by the internalized nanorockers allowed us to 
determine the time evolution of their accumulated angular displacement and, from this, the 
intracellular viscosity. Our results show a correlation between drug administration and 
alterations in the intracellular viscosity of HeLa cells, so that accurate monitoring of the 
treatment becomes possible. We have observed that the intracellular viscosity of HeLa cells 
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decreases as the incubation time with Taxol increases. On the other hand, as the concentration 
of colchicine is increased above a threshold, the viscosity of the cell also does. These results 
are comparable to those obtained for neutrophil and macrophage cells treated with the same 
drugs. 
In addition, we analyze the experimentally measured viscosity in terms of the structural 
changes produced on the cytoskeleton of the cells and numerical simulations of the diffusion 
of the nanorocker, to understand the effect of the studied chemical treatments on HeLa cells. 
We conclude from our results that the chemically-induced viscosity variations are an ultimate 
consequence of the alteration in the polymerization/depolymerization dynamics of the 
microtubules, rather than the actin filaments. This modifies the average size of the 
intracellular components, changing the effective viscosity that drags the movement of the 
nanorocker. A more detailed study could be done with a range of particle´s sizes in order to 
assess the viscosity changes at different scales. 
Our work shows the use of non-spherical upconverting nanoparticles as intracellular 
rheometric sensors to monitor changes in the intracellular viscosity produced by 
chemotherapeutic treatments. This will help with the development of new chemotherapies 
and single-cell studies. 
5. Experimental Section  
Experimental setup: The 980 nm laser radiation generated by a fiber-coupled laser diode 
(Lumics GmbH) was collimated and expanded to slightly exceed the back aperture of the 
microscope objective (Optika, LWDPLAN, 60 ×, NA = 0.7) that was used to create a 
diffraction-limited beam spot. We used the same objective to collect the luminescence of the 
excited UCNP and to image the sample plane using a CMOS camera (Thorlabs, DCC1645C). 
The spectral distribution of the nanoparticle’s luminescence was analyzed using a CCD 
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camera (Horiba, Synapse) coupled to a monochromator (Horiba, iH320). We used optical 
filters (Thorlabs, FESH950) to block the laser light from reaching both cameras. 
We analyze the cells directly in the same petri dish in which they were grown, incubated with 
the UCNPs and treated. They were always kept immersed in the culture medium. We kept the 
cells in a warm environment and translated individual dishes to the optical setup for the 
viscosity measurements. We continuously monitored the cell state during the experiments and 
we discarded samples if any sign of deterioration was observed. 
Cell preparation for chemotherapy studies: We cultured HeLa cancer cells (ATCC) to 50 - 
60 % confluence at 37 °C in 10 % Dulbecco’s Modified Eagle’s Medium supplemented with 
10 % bovine calf serum, 50 units/mL penicillin and 50 g/mL streptomycin (Sigma). To 
introduce the luminescent probes inside the cells, we incubate them for 2 h with a diluted 
colloidal solution of the nanorockers in PBS. Then, we washed the cultures several times to 
eliminate the particles not internalized by the cells. After that, we subjected the cells to 
different chemical treatments. To alter the microtubules of the cytoskeleton and, thus modify 
the intracellular viscosity, we treated the cells for different periods of time (0.5, 1, 2, 3, and 5 
h) with 0.2 µM paclitaxel (Taxol) to promote polymerization of tubulin into microtubules or 
with 0.1, and 1 µM colchicine for 2 h, to collapse cellular microtubules. Colchicine and 
paclitaxel were purchased from Sigma Chemical (St. Louis, MO). After all drug treatments, 
we washed the cultures several times to remove the chemicals from the culture medium. 
Rheometric technique: The viscosity of the medium is related to the rocking movement of the 
particle through the mean square angular displacement (MSAD) (see Equation 1). We obtain 
this parameter from the evolution of the angular displacement of the particle (θ) with time 
(i.e. 𝑀𝑆𝐴𝐷(𝑡) = ⁡∑ (𝜃𝑖 − ?̅?)
2𝑡𝑖
𝑡=0 , where θi is the orientation of the particle at time ti and ?̅? is 
the mean value of the angular displacement). We calculated the angular displacement at a 
given time from the emission spectrum using Equation 2. To do so, we analyze the polarized 
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emission of the particle to determine its orientation. We obtain the maximum value of the 
intensity ratio between the peaks centered at 654 nm and 661 nm (corresponding to the 
vertical orientation) from the set of spectra (see Figure 2a and b). The minimum intensity 
ratio is set to a reference value that we obtain as the mean value of the intensity ratio of a set 
of UCNPs stuck on a surface in the horizontal orientation. We tested possible variations 
between the actual minimum ratio and the reference value and we saw that results deviated 
less than the experimental uncertainty. We used this maximum and minimum values in 
Equation 2, together with the intensity ratio computed at each time instant, to obtain the 
angular displacement θi. Then, we obtain the evolution of the MSAD and fitted it to a linear 
function to obtain a value of the viscosity. The values we used for the volume and Perrin’s 
friction coefficient were calculated from the mean particle´s size obtained from SEM images. 
We used the luminescence emission of the UCNPs to locate them within the cells. We only 
used one particle per cell. Once a UCNP was found in the same location as a cell, we check 
its internalization. To do so, we changed the position of the excitation focus to ensure that the 
maximum detected intensity corresponded to a plane within the volume of the cell. From this 
we concluded that the particle was internalized rather than on the upper membrane of the cell. 
Cell preparation for immunodetection assay: We grew cells on round coverslips placed into 
24-well plates. For tubulin detection (microtubule visualization), we fixed the cells in cold 
methanol (-20 ºC) for 7 min. After washed in PBS, we incubated the cells with alpha-tubulin 
(Sigma) primary antibody for 1 h at 4 ºC, in 0.1 % PBS/BSA. Then we washed the cells twice 
with PBS and incubate them with Alexa-488 (Invitrogen) secondary antibody (1:500 in 0.1 % 
PBS/BSA), also for 1 h at 4 ºC. Finally, we washed the cells again. 
For F-actin detection (actin filaments visualization), we fix, stained and permeabilized the 
cells in a single step by the addition of a 2X cold solution containing 5 units/ml Alexa 546-
labeled phalloidin (Molecular Probes), 0.5 mg/ml L-α-lysophosphatidyl-choline, and 3.5 % 
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formaldehyde in PBS. After 20 min at 4 °C, we washed the cells twice in cold PBS. Finally, 
all samples were mounted in Prolong-GOLD (Molecular Probes). 
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Figure 1. (a) Schematic representation of the experimental setup used to measure the 
intracellular viscosity composed by the excitation beam, a CMOS camera to visualize the 
sample, and a monochromator coupled to a CCD camera to measure the luminescence 
spectrum of the internalized upconverting nanoparticles (UCNPs). A typical SEM image of 
the UCNPs is included. (b) HeLa cells are incubated with the UCNPs and subjected to the 
different drug treatments. Once inside the cell, (c) the UCNP is surrounded by microtubules 
that affect its Brownian motion. The microtubules are (d) hollow tubes formed by 
heterodimers that dynamically assembly and disassembly. 
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Figure 2. For the determination of the intracellular viscosity, we measure (a) consecutive 
luminescent spectra from a single nanorocker located inside a HeLa cell. We then use the 
highlighted peaks to determine the (b) intensity ratio (I654/I661) that gives the angular position 
of the particle through Equation 2. We finally use this angular position as a function of time 
to calculate the (c) evolution of the mean square angular displacement (MSAD) which we 
used to determine the intracellular viscosity using Equation 1. Black and blue curves 
correspond to the mean value of the MSAD of particles internalized in Taxol-treated cells 
incubated for 0.5 and 5 h, respectively. Gray bars represent the statistical error of different 
measurements. 
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Figure 3. (a) Decrease in the intracellular viscosity as the incubation time with Taxol (at a 
concentration of 0.2 µM) increases. Blue data represents the experimental results, while the 
black dashed line is the best exponential decay fit. (b) Intracellular viscosity for cells 
incubated for 2 h with two different colchicine concentrations. Only the higher concentration 
of 1.0 µM produces an increase in the viscosity. Data correspond to the mean obtained value 
and error bars represent the standard deviation of all measurements performed for each 
treatment conditions. Results for untreated cells are also shown.  
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Figure 4. Fluorescence images of two components of the cytoskeleton of untreated and 
treated HeLa cells. Tubulin is marked in green, while actin is colored in red. Control cells 
were not subjected to any chemical treatment. Cells incubated with Taxol at a concentration 
of 0.2 µM for 2 and 5 h (second a third columns, respectively) present microtubules forming 
bundles due to the stabilization produced by this drug. On the other hand, the microtubule 
network of cells treated with 1 µM of colchicine (fifth column) is partially destroyed. This 
effect cannot be seen in cell incubated at 0.1 colchicine concentration (fourth column). Actin 
filaments do not present alterations due to the drug treatments. Only the microtubule network 
(formed by tubulin) is directly affected during the drug treatments. Scale bar is 10 µm. 
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Figure 5. (a) Representation of the different elements of the computational model used to 
study the effect of microtubules in the dynamics of the nanorocker. (b) Computed and 
experimentally measured mean squared angular displacement (MSAD) over time. 
Comparison is made between simulations of free (red line) and laser-illuminated (confined, 
green line) nanorocker, surrounded by 10 microtubules (MT), and the experimental results 
(Exp.) after 5 h incubation time with Taxol (blue data). The orange line represents the MSAD 
calculated from Equation 1 using the measured viscosity for an incubation time of 5 h. The 
good agreement between orange and blue curves validates the approximation of the 
nanorocker to a disk. The inset shows the mean squared displacement (MSD) for free 
nanorockers in the presence of 0, 5 and 10 microtubules. The agreement between the 
experimental and simulation results indicates that the movement of the particle is not affected 
by the presence of microtubules since their size is much bigger than the particle. 
 
 
 
 
  
